{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:28:18Z","timestamp":1794569298327,"version":"4.9.1"},"reference-count":42,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca corrente"],"award-info":[{"award-number":["Ricerca corrente"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2023,3,15]]},"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Phosphorylated-tau181 (p-tau181), a specific marker of Alzheimer\u2019s disease (AD) pathology, was found elevated in plasma but not in cerebrospinal fluid (CSF) of patients with amyotrophic lateral sclerosis (ALS). We expanded these findings in a larger patient cohort, exploring clinical\/electrophysiological associations, prognostic value and longitudinal trajectories of the biomarker.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We obtained baseline plasma samples from 148 ALS, 12 spinal muscular atrophy (SMA), and 88 AD patients, and 60 healthy controls. Baseline CSF and longitudinal plasma samples were from 130 and 39 patients with ALS. CSF AD markers were measured with the Lumipulse platform, and plasma p-tau181 with SiMoA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients with ALS showed higher plasma p-tau181 levels than controls (p&lt;0.001) and lower than AD participants (p=0.02). SMA patients had higher levels than controls (p=0.03). In patients with ALS, CSF p-tau and plasma p-tau181 did not correlate (p=0.37). Plasma p-tau181 significantly increased with the number of regions showing clinical\/neurophysiological lower motor neurons (LMN) signs (p=0.007) and correlated with the degree of denervation in the lumbosacral area (r=0.51, p&lt;0.0001). Plasma p-tau181 levels were higher in classic and LMN-predominant than in bulbar phenotype (p=0.004 and p=0.006). Multivariate Cox regression confirmed plasma p-tau181 as an independent prognostic factor in ALS (HR 1.90, 95% CI 1.25 to 2.90, p=0.003). Longitudinal analysis showed a significant rise in plasma p-tau181 values over time, especially in fast progressors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Plasma p-tau181 is elevated in patients with ALS, independently from CSF levels, and is firmly associated with LMN dysfunction. The finding indicates that p-tau181 of putative peripheral origin might represent a confounding factor in using plasma p-tau181 for AD pathology screening, which deserves further investigation.<\/jats:p><\/jats:sec>","DOI":"10.1136\/jnnp-2022-330709","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:11:02Z","timestamp":1680567062000},"page":"428-435","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":48,"title":["Elevated plasma p-tau181 levels unrelated to Alzheimer\u2019s disease pathology in amyotrophic lateral sclerosis"],"prefix":"10.1136","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3607-2394","authenticated-orcid":false,"given":"Veria","family":"Vacchiano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mastrangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Zenesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Baiardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Avoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Polischi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Capellari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9444-9524","authenticated-orcid":false,"given":"Piero","family":"Parchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"2024102902001104000_94.6.428.1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.85"},{"key":"2024102902001104000_94.6.428.2","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2016.1267768"},{"key":"2024102902001104000_94.6.428.3","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-014-1299-6"},{"key":"2024102902001104000_94.6.428.4","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000001098"},{"key":"2024102902001104000_94.6.428.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01382-x"},{"key":"2024102902001104000_94.6.428.6","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.1534"},{"key":"2024102902001104000_94.6.428.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01384-9"},{"key":"2024102902001104000_94.6.428.8","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13698"},{"key":"2024102902001104000_94.6.428.9","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(21)00214-3"},{"key":"2024102902001104000_94.6.428.10","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-022-01093-6","article-title":"Diagnostic value of plasma p-Tau181, NFL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias","volume":"14","author":"Baiardi","year":"2022","journal-title":"Alzheimers Res Ther"},{"key":"2024102902001104000_94.6.428.11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001642"},{"key":"2024102902001104000_94.6.428.12","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-311387"},{"key":"2024102902001104000_94.6.428.13","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-318704"},{"key":"2024102902001104000_94.6.428.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09761-z"},{"key":"2024102902001104000_94.6.428.15","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.753242","article-title":"Plasma and CSF neurofilament light chain in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study","volume":"13","author":"Vacchiano","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"2024102902001104000_94.6.428.16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009559"},{"key":"2024102902001104000_94.6.428.17","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000218161.15834.db"},{"key":"2024102902001104000_94.6.428.18","doi-asserted-by":"publisher","DOI":"10.3109\/17482968.2011.622405"},{"key":"2024102902001104000_94.6.428.19","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-016-0301-z","article-title":"Pathological tau deposition in motor neurone disease and frontotemporal lobar degeneration associated with TDP-43 proteinopathy","volume":"4","author":"Behrouzi","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"2024102902001104000_94.6.428.20","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00259","article-title":"Phosphorylation of threonine 175 tau in the induction of tau pathology in amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD). A review","volume":"12","author":"Moszczynski","year":"2018","journal-title":"Front Neurosci"},{"key":"2024102902001104000_94.6.428.21","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nlz041"},{"key":"2024102902001104000_94.6.428.22","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.6064"},{"key":"2024102902001104000_94.6.428.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2014.10.019"},{"key":"2024102902001104000_94.6.428.24","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14789"},{"key":"2024102902001104000_94.6.428.25","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26462"},{"key":"2024102902001104000_94.6.428.26","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30071-5"},{"key":"2024102902001104000_94.6.428.27","doi-asserted-by":"publisher","DOI":"10.1080\/146608200300079536"},{"key":"2024102902001104000_94.6.428.28","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002923"},{"key":"2024102902001104000_94.6.428.29","unstructured":"Alzheimers Dement . 2020 alzheimer\u2019s disease facts and figures. 2020."},{"key":"2024102902001104000_94.6.428.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.005"},{"key":"2024102902001104000_94.6.428.31","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.184"},{"key":"2024102902001104000_94.6.428.32","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008869"},{"key":"2024102902001104000_94.6.428.33","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr351"},{"key":"2024102902001104000_94.6.428.34","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2016.1265565"},{"key":"2024102902001104000_94.6.428.35","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2018.1484925"},{"key":"2024102902001104000_94.6.428.36","doi-asserted-by":"publisher","DOI":"10.1007\/S00415-021-10521-W"},{"key":"2024102902001104000_94.6.428.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2007.09.143"},{"key":"2024102902001104000_94.6.428.38","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.697"},{"key":"2024102902001104000_94.6.428.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2010.06.027"},{"key":"2024102902001104000_94.6.428.40","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.598907","article-title":"Alterations in tau metabolism in ALS and ALS-FTSD","volume":"11","author":"Strong","year":"2020","journal-title":"Front Neurol"},{"key":"2024102902001104000_94.6.428.41","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.308077"},{"key":"2024102902001104000_94.6.428.42","doi-asserted-by":"publisher","DOI":"10.1038\/s10038-022-01055-8"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2022-330709","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T09:00:21Z","timestamp":1730192421000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2022-330709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,5,15]]},"published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1136\/jnnp-2022-330709"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2022-330709","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]}}}